🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical study is to learn more about the effects of switc...
Status
Active Not Recruiting
Location
Be Well Medical Center
Start Date
2022-08-16
Trial ID
NCT05502341
Treatments Being Tested
The goal of this clinical study is to provide continued access to the study...
Status
Recruiting
Location
Helios Salud
Start Date
2024-08-27
Trial ID
NCT06337032
Treatments Being Tested
Dolutegravir (DTG) and lamivudine (3TC) are indicated in combination with o...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-05
Trial ID
NCT02738931
The primary objective of this study is to evaluate the efficacy of switchin...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-08-28
Trial ID
NCT03631732
Treatments Being Tested
This study will compare safety, efficacy, and tolerability of a two drug re...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-07-18
Trial ID
NCT02831764
Treatments Being Tested
First-line antiretroviral regimens are highly efficacious and generally wel...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-05-06
Trial ID
NCT03682848
Treatments Being Tested
Protocol Title: DOLCE: Dolutegravir-Lamivudine for naïve HIV-Infected Patie...
Status
Completed
Location
Fundación Huésped
Start Date
2021-05-17
Trial ID
NCT04880395
This is a multicenter, single arm, 96-week open-label study of the safety a...
Status
Completed
Location
University of North Carolina
Start Date
2015-09
Trial ID
NCT02384395
Treatments Being Tested
This study is designed to demonstrate the non-inferior antiviral activity o...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-08-22
Trial ID
NCT01910402
Treatments Being Tested
In this study, the dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) fixed dos...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-17
Trial ID
NCT02075593
Treatments Being Tested